Tabelecleucel is effective in EBV-positive lymphoproliferative disease
Crossref DOI link: https://doi.org/10.1038/s41571-024-00873-3
Published Online: 2024-02-19
Published Print: 2024-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2024-02-19
Version of Record valid from 2024-02-19
Article History
First Online: 19 February 2024